Advice Pool
#1 in Business Subscribe Email Print

You are here: Home > Legal > Cyber Law > Copyrighting Themselves Out of Business

Tags

  • havent
  • number
  • offenders
  • combination products

  • Links

  • How To Make A Cup Of Tea
  • Timing Clauses Stop Sellers From Inciting Bidding Wars
  • Pros and Cons of IM and Phone for Online Dating
  • Advice Pool - Copyrighting Themselves Out of Business

    If there is any industry who is less out of touch with its customers than the music industry then I defy it be suggested. As if going after die-hard fourteen year-old Coldpla
    According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
    y fans wasn’t enough, record companies are now extending their copyright war by taking legal action against websites that offer unsolicited music scores (BBC news). When are
    ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

    Examples of combination products may in
    the CEO’s of these belligerent organisations going to wake up and realise that you don’t make money suing your customers?

    Since the arrival of MP3 files, record company chie
    lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

    fs have been on nothing short of a witch hunt to identify the key perpetrators of their traditionally gargantuan and monopolistic hold over music buyers, fining key offenders
    here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
    of the Copyright Law up to sums of $150,000. Unlike their plans to prosecute websites ‘illegally’ publishing music scores however, the disolusioned Chief Executives and thei
    d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

    Combination pro
    r equally moronic corporate camaraderie of amateur A&R producers haven’t been able to touch offending sites like KaZaa, Grokster and Morpheus for as far as legalese is concer
    ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
    ned, these sites are just ‘pipelines’ and the prosecutable offenders are, unfortunately, individuals.

    Most industry chiefs would have acknowledged, logically enough, that th
    easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
    sheer number of offenders was too overwhelming on both time and cashflow to address through the courtroom and responded to the problem by trying to provide some alternative
    nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
    platform for distribution to the one their ‘customers’ were currently using, offering features which made them want to pay for it. But the Magnates of Music have never much c
    and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
    ared for treating their customers with courtesy, and they weren’t about to start this time round.

    What has transpired is a five-plus year spending spree of what can only be
    ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
    described as cringeable management practice, with the net result of most legal campaigns – even richer prosecuting attorneys. In the process, record companies have done littl
    ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

    Following aspects would a
    e else but whine to anti-trust regulators about how margins are being squeezed and get away with outrageously gargantuan mergers the likes of which would be inconceivable in
    dd to the challenges in developing combination products:

    Which markets to tap where the combination products can do fairly well?
    Which combination prod
    any other industry.

    “The problem for major record companies is that they are less music publishers than they are music retailers” one industry executive told me at a party i
    cts are meaningful and rational?
    Which therapeutic categories to select?
    Which Combinations can address unmet needs of the patients?
    Do combin
    n London earlier this year. “Where they make their money is in the in-store margins, in selling CD’s. Record companies have been clamping down so hard on copyright because it
    tions increase the patient compliance?
    What would be the developing cost?
    How to tackle the risks encountered during combination product developmen
    s the income stream.”

    Well that, and the fact that these companies are led by poorly-trained Chief Executives who have little understanding and no interest in learning about
    t?

    As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
    the dynamics of disruptive technologies. One can’t help but speculate whether had EMI spent the same time and money on developing “EMI-Tunes” as it has wearily suing teenage
    ping new procedures for reviewing their safety, efficacy and quality.

    Professional from academic institutions, pharmaceutical industries, health care indust
    rs over the past five years whether its balance sheet and stock price might not look considerably healthier.

    Still, the news shows that they haven’t got the message yet, or
    y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
    the irony that they are suing themselves out of business as savvier competitors like Apple cash in on massive consumer demand, for the truth is, prosecuting two hundred and f
    .

    As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
    ifty offendors a year is not going to stop the other sixty million people from changing habits that mean more convenience and less hassle.

    The rule “stay close to your compe
    elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

    Companies that provide selfless information through particip
    titor” was immortalised by Tom Peters and is almost universal today: His Master's Voice should do a little less shouting and a little more heeding of the voices of the masses


    tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

    HTTP = HTML link (for blogs, profiles,phorums):
    <a href="http://www.advicepool.org.ua/article/129551/advicepool-Copyrighting-Themselves-Out-of-Business.html">Copyrighting Themselves Out of Business</a>

    BB link (for phorums):
    [url=http://www.advicepool.org.ua/article/129551/advicepool-Copyrighting-Themselves-Out-of-Business.html]Copyrighting Themselves Out of Business[/url]

    Related Articles:

    Compare Health Insurance Rates Online

    Life Insurance Fears Post the London Bombings Tragedy

    Live on a Yacht Tax Free

    Bookmark it: del.icio.us digg.com reddit.com netvouz.com google.com yahoo.com technorati.com furl.net bloglines.com socialdust.com ma.gnolia.com newsvine.com slashdot.org simpy.com shadows.com blinklist.com